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Towards a Medically Approved Technology
for Large-Scale Stem Cell Banks: Tools and Methods
The importance, of the development of stem cell cryobanking has increased recently with an augmentation of stem cell research and
its therapeutic applications. The development of therapies is, among other things, limited by high sensitivity of stem cells to freezing-
thawing procedures. Thus, new approaches are needed for preservation and related evaluation methods, as well as new technologies for
long term storage of large numbers of stem cells. Here we present selected recent improvements of stem cell cryopreservation, e.g. for
freezing of adherent human embryonic stem cells using gel-like matrices. We report the application and performance of novel micro-
system-based cryosubstrates and devices and describe new evaluation methods and the results of a thermal stress cycle study.
Key-words: human embryonic stem cells, cryopreservation, stem cell banking, cryomicroscopy, cryotechnique, scanning electron
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В настоящее время возросла важность развития криобанков стволовых клеток в связи с их расширенным изучением и
терапевтическим применением. Однако, наряду с другими факторами, вышеуказанная терапия ограничена высокой
чувствительностью стволовых клеток к процедурам замораживания-оттаивания. Необходимы как новые подходы к
криоконсервированию и связанным с ним методам оценки, так и новые технологии для долгосрочного хранения большого
количества стволовых клеток. В настоящей работе мы представляем некоторые улучшенные методы криоконсервирования
стволовых клеток, например замораживание эмбриональных стволовых клеток человека с использованием гелеобразного
матрикса. Мы представляем результаты применения разработанных на базе микросистемной техники новых криосубстратов
и устройств, а также описываем новые методы оценки и результаты изучения циклов температурного стресса.
Ключевые слова: эмбриональные стволовые клетки человека, криоконсервирование, банк стволовых клеток,
криомикроскопия, криогенная техника, сканирующая электронная микроскопия.
Наразі зросла важливість розвитку кріобанків стовбурових клітин у зв’язку з їх розширеним вивченням і терапевтичним
застосуванням. Але водночас з іншими факторами вищезгадана терапія обмежена високою чутливістю стовбурових клітин
до процедур заморожування-відтавання. Необхідні як нові підходи до кріоконсервування та повязаних з ним методам оцінки,
так і нові технології для довгострокового зберігання великої кількості стовбурових клітин. В цій роботі ми представляємо
деякі покращені методи кріоконсервування стовбурових клітин, наприклад заморожування ембріональних стовбурових клітин
людини з використанням гелеподібного матриксу. Ми представляємо результати застосування розроблених на базі
мікросистемної техніки нових кріосубстратів та приладів, а також описуємо нові методи оцінки і результати вивчення циклів
температурного стресу.
Ключові слова: ембріональні стовбурові клітини людини, кріоконсервування, банк стовбурових клітин, кріомікроскопія,
кріогенна техніка, скануюча електронна мікроскопія.
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Interest in stem cell transplantation for therapy of
degenerative disorders has intensified recently. These
therapies need a reliable and safe supply of high-qua-
lity stem cells or stem cell-derived progenitors. Long
term preservation of stem cells without loss of vitality
and functionality can only be achieved by low tempe-
rature conservation, so-called cryopreservation with
storage over liquid nitrogen (for review see Hunt, 2007
[12]). Current cryobanking relies on storing sources
of stem cells such as umbilical cord blood [29], but
the reliable banking of defined, well-characterized
stem cells (both somatic and embryonic) and condi-
tions for secure outgrowth are still in the stage of infan-
cy. The general problems of cryobiology create spe-
cific problems for sensitive primary stem cells. For
example, it is known that damage occurs during
freezing and thawing from ice crystallisation and re-
crystallisation. To protect cells from these processes
and solution effects, most current cryopreservation
methods control freeze/thaw velocity and use cryopro-
tectants that influence the water content of cells. Slow
freezing and rapid warming to balance cell dehydration
[25] is the most effective freezing procedure at the
moment. There are two main groups of cryoprotec-
tants: penetrative and non-penetrative [5, 26]. Among
penetrative cryoprotective agents (CPA), dimethyl
sulfoxide (Me2SO) [27] is still the most important and
effective (other include glycol, ethylene glycol etc.)
[23]. Some non-penetrative CPA such as hydroxyethyl
starch (HES) or polyethylene glycol can induce glass-
like solidification, so-called vitrification, eliminating
ice crystal formation [4, 26]. Both types of CPA are
used for cryopreservation of stem cells [7–11, 14, 15,
19, 31, 32, 36, 37, 39]. However, at present robust,
optimised cryopreservation protocols, especially for
human embryonic stem cells (hESCs) are still not
achieved. We lack imaging technology; require the
development and evaluation of optimal freezing media,
compounds and CPA; need to establish validation
methods and need to optimise new approaches for
freezing, using two- and three-dimensional structures
including scaffolds and encapsulation, etc [12, 43].
For future cryobanking it is essential to create new
cryosubstrate platforms for most types of cells and
tissues. These substrates have to provide the best
biophysical parameters for freezing; have to be suitable
for storage of high numbers of objects; must be cell
specific, informative for users, work flow specific and
data sensitive. This can be achieved using modern
production processes, like micro-system technology,
a novel tool in cryopreservation technology [13, 41].
Cryobanking of stem cells requires safe long-term
storage without marked loss of post-thaw viability and
functionality [35]. However, there are no available
systems for investigating the influence of changes in
temperature and other parameters on long-term storage
of cells. This and other above indicated problems are
focus points of this paper.
New micro-system based devices for cell and
tissue cryopreservation
The development of stem cell therapies requires
new approaches to cell freezing and storage equip-
ment. The cell containers of current cryopreservation
technology are plastic cryovials with a minimum
volume of 1 ml. These are suitable for ~107 cells and
the whole volume must be thawed at once for use.
New micro-system (MST) based devices for cryopre-
servation and cryobanking of single- and multi-cellular
systems can be useful in modern cryobiotechnology
[41]. The main principles of those devices are miniatu-
risation, modulation and storage of information about
cryopreserved objects on a chip directly connected to
the cryosubstrate [13, 41]. Using those devices it was
found that Me2SO concentration can be reduced to
~2% without adversely affecting post-thaw viability,
this is consistent with recent literature [24, 40, 41].
One type of new cryocontainer is shown in Fig. 1a. It
consists of 30 wells, each of 25 µl. It can be closed
either with a heat-sealing film or by a snap on lid and
is suitable when large numbers of samples have to be
stored in a small space. After filling with cells, CPA
can be added by a micropipette robot (Fig. 1b) capable
of accurately dispensing nano-liter volumes. Gene-
rally, these substrates and automatic CPA addition
allow Me2SO concentrations to be reduced from the
conventional 10% to ~2% [41]. Some cell types such
as mouse fibroblasts [40, 41], epithelial tumour cells
[24] show higher post-thaw vitalities when frozen in
these containers rather than in conventional cryovials.
These containers are not limited to cell suspensions
and have also been used successfully to freeze multi-
cellular systems such as Langerhans’ islets and tumour
spheroids [18] The first cryopreservation of CEpan3b
human adult stem cells in micro-cryosubstrates is
presented in this paper. CEpan3b cells were isolated
from pancreatic acini (for details see Kruse et al. [21,
22]). Cells were cultured in DMEM (Invitrogen, Paisley,
UK) supplemented with 10% FBS Gold (PAA, Austria)
and 1000 U/ml Penicillin/Streptomycin (Invitrogen,
Paisley, UK) under standard conditions (37°C, 5%
CO2). Cells were sub-cultured so that they remained
in exponential growth phase. Harvesting was done by
trypsination (Trypsin/EDTA; Invitrogen, Paisley, UK).
For cryopreservation a cell density of 0.5–1×106 cells/ml
was calculated by counting the cells in a haemocyto-
meter. Cell viability was assed by ethidium bromide
(EB) and fluorescein diacetate (FDA) [1]. FDA is able
to cross plasma membrane, in metabolic cells it is hyd-
rolysed and free fluorescein accumulates inside the
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cells (green fluorescence). EB is only able to pass da-
maged plasma membranes and intercalate into DNA
(red emission).
A pipette robot (GeSim, Rossendorf, Germany)
added Me2SO (WAK-Chemie, Germany) to cells in
the wells of miniaturised cryosubstrates (Fig. 1a) for
a total volume of 25µl. CPA was manually added to
cryovials with a total volume of 1ml. Me2SO concen-
trations of 0.5 to 10% were used. Cell suspensions
containing Me2SO were incubated for 30 min at 4°C
before freezing with 1°C/min rate to –80°C in a
computer controlled freezing device (Kryo10-MRIII,
Planer Systems, UK). Until thawing, samples were
stored in vapour phase of liquid nitrogen. Thawing was
achieved by placing cryovials into a 37°C water bath
for approximately 3 min. Micro-cryosubstrates were
placed for 5min into an incubator. Cell vitality was
immediately assed by double staining with EB/FDA.
Vitality was calculated as: 100% × number of living
cells/(number of living cells + number of dead cells).
Fig. 2 shows the post-thaw vitality with standard devia-
tion of CEpan3b cells frozen in miniaturised cryosub-
strates and cryovials with varying concentrations of
Me2SO. For concentrations between 2% and 10%
vitalities ranged from 77% (±15%) to 90% (±5%). The
vitalities obtained for both systems were comparable
for all experimental trials. However, on decreasing
Me2SO concentration to 1% and 0.5% vitality dropped
to 45% and 16–26% respectively. Experiments were
repeated for all concentrations except 5% four times,
the 5% samples were repeated for twelve times. Our
results demonstrate vitalities of more than 80% at 2%
Me2SO (Fig. 2). However, in this case there was no
no marked effect of container geometry.
A second container that allows cell manipulation
and cryopreservation is shown in Fig 1e. This includes
Fig. 1. New micro-system based devices for cryopreservation: a – IBMT-micro-cryosubstrate; b – micropipetting nanoplotter
for automatic addition of cryoprotectants; d, e and f – CellProm micro-cryosubstrate: 1 – cap, 2 – retainer, 3 – socket
extension, 4 – frame for carrier insert; f – CellProm carrier insert with cultured cells; c and g – integrated cryoprotectant
dispenser for generation of compartments with cells and automatic CPA addition in a polymer-chip; c – polymer-chip; g –
high speed frames of generation of compartments (dark grey) with multicellular spheroids (asterisk); scale bar in figure 1f
1000 µm.
Fig. 2. Post-thaw vitalities of the human adult stem cell line
CEpan3b. Cells were frozen in IBMT miniaturised
cryosubstrates (grey bars) and commercial 1ml cryovials
(white bars). Post thaw vitality was assayed by double
staining with fluorescein diacetate and ethidium bromide
and was calculated as percentage of living cells divided
through total cell number. Experiment were repeated four
times (twelve times for 5% DMSO). The error bars are
standard deviations.
Me2SO concentration in culture medium, %
Vi
ta
lit
y,
 %
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a small glass carrier suitable for the culture of adherent
cells (Fig. 1f) and for microscopy. In addition, the carrier
can be transported magnetically for various process
steps.
Also a new MST-based polymer chip with an
integrated dispenser for generation of compartments
containing cells or multi-cellular spheroids has been
created recently. Fig.1c and g shows a simple fluidic
system that incorporates a CPA dispenser. As
spheroids are transported in small compartments of
medium (right to left in Fig. 1g) the CPA is added
automatically with very rapid mixing. In this system
automatic addition of cryoprotectants in nano-liter
volume was realized with a micro-fluidic pump. The
creating of compartments with multi-cellular spheroids
is visible in Fig.1g (Fig. 1g; spheroids marked with
asterisk). This picture is a part of a high speed video
of this process. One compartment consists of only 65
nl (Fig. 1g) and can be frozen in an computer controlled
freezing device. First experiments with this system
showed promising results with rat pancreatic islets as
a new approach for cryobanking. There are also
cryocontainers (of 100–2000 ml capacity) that
incorporate flash memory chips for the storage of
sample-related data and identification. With suitable
electronic infrastructure, these memories can be inter-
rogated while at liquid nitrogen temperature [13]. This
close association of data and sample greatly reduces
the possibility of book-keeping errors and gives the
ability to locate a particular sample without opening
the cryotank.
The presented cryosubstrates together with new
electronic infrastructure for cryorepository and new
cryopreservation methods [42] open new perspectives
for medical relevant cell preservation, especially, for
stem cell cryopreservation.
Validation technology for freezing
procedures
Successful medical application of cryopreserved
stem cells is not possible without validation of freez-
ing/thawing procedures. It is necessary to observe and
understand ice crystallization processes with and
without different cryoprotectants. Cryomicroscopy,
using a conventional microscope connected with freez-
ing/thawing system and recording camera, is a power-
ful tool in this field [2, 20]. A high speed camera [3]
allows visualization of very fast intra- or extracellular
ice front propagation. A similar set up was recently
used for studies of ice propagation in and around
adherent endothelial cells on micropatterned substrates
[33]. We have used high speed cryomicroscopy for
the first time to analyse ice crystallization with CPA
addition in multicellular systems [43]. Here we extend
these experiments and have firstly used high-speed
video cryomicroscopy with embryonic stem cells and
encapsulated pancreatic islets. Our system uses a
modified microscope (Nikon Eclipse 80i, Nikon, Japan).
The cryostage (MDS 600; Linkam, England) is con-
nected to a temperature controller (TMS 94), a pump
(all Linkam) and a Dewar for supply of liquid nitrogen.
The observation window is purged by dry nitrogen gas.
Images are recorded with a digital camera (Pixelink,
Germany) connected to the Linksys32 software or a
high-speed camera (SpeedCam Visario LT400, Wein-
berger, Switzerland) capable of up to 4000 frames/sec.
H1 embryonic stem cells, obtained from WiCell
(Madison, WI, USA), were cultured onto Mitomycin C
inactivated embryonic mouse fibroblasts strain CF-1
(Millipore, Billerica, MA) and passaged under stan-
dard conditions recommended from WiCell (Introduc-
tion to human embryonic stem cell culture methods;
Part IV – splitting human embryonic stem cells,
January 2003). Culture medium was modified by the
addition of 100 U/ml penicillin and 100 µg/ml strepto-
mycin (all medium components Invitrogen, UK). H1
colonies were picked from culture plates and incubated
in culture medium, then transferred into cryopreserva-
tion solution for high-speed cryomicroscopy. The cryo-
preservation solutions were 285 mM trehalose (Sigma-
Aldrich Chemie GmbH, Schnelldorf, Germany) + 5mM
KCl (Merck, Darmstadt, Germany) + 5mM histidine
(Merck, Darmstadt, Germany) or culture medium +
30% FBS (final concentration 27%) + 10% Me2SO.
Colonies were kept in these media for 5–10 min before
freezing. The freezing rate was 10°C/min from 4°C to
–80°C. Samples were thawed at 40°C/min. For
cryomicroscopy of encapsulated pancreatic islets, the
islets were isolated from young Sprague-Dawley rats
(CD-rats) (for details see [34]) and encapsulated with
0,65% NT-alginate, dissolved in 0,9% NaCl, using an
encapsulation machine described in Zimmermann et
al. 2005 [42]. After encapsulation, islets were culti-
vated overnight in an incubator at 37°C, washed once
with culture medium supplemented with 7% Me2SO
added by micro-pipette robot (GeSiM, Rossendorf,
Germany) at 4°C and incubated at 4°C for 30 min
before freezing. For cryomicroscopy, samples were
frozen with at 1°C/min from 4°C to –80°C and thawed
at 40°C/min.
Fig. 3 shows how the ice front is structured,
distorted and redirected when passing the H1 colonies
and capsules. Furthermore, Fig. 3(a–c) illustrates that
when cryomedium contains Me2SO, cells in the colony
darken. This means that cells are frozen and the light
refracted. In contrast, cells tend to vitrify rather than
freeze if the extracellular cryoprotectant trehalose
(isoosmolar solution) is used (Fig 3(d–f)). Though,
devitrification occurs upon thawing, accompanied by
the so-called “flash out” effect (data not shown).
472 PROBLEMSOF CRYOBIOLOGY
 Vol. 18, 2008, №4
ПРОБЛЕМЫ
КРИОБИОЛОГИИ
Т. 18, 2008, №4
front. As shown in pictures k and l the ice front goes
around the capsule and freezing of the capsule takes
place later (data not shown).
For human embryonic stem cells, the whole colo-
ny freezes by addition of Me2SO (Fig. 3(a–c). This
effect has already been clearly shown for pancreatic
islets; the growth of extra-cellular ice occurs first and
intracellular ice forms later [2]. If frozen in a solution
Fig. 3. High speed cryomicroscopy of freezing situations in different systems a–c: H1 colony frozen in cryo medium +
10% Me2SO. In frame b you can see the ice front (visualised by a black dashed line) grows over the colony. In c, the ice is
structured between the front and the colony and the cells freeze (become dark). d–f: H1 colony in isoosmolar trehalose
solution. In frame d  ice front (visualised by a black dashed line) accelerates when reaching the colony (e) and the ice is
structured everywhere (f). g–i: H1 colony frozen in cryomedium + 10% Me2SO. The upper line in pictures g and h
illustrating the border of the colony. The lines within the colony are drawn between two cells. The number in the external
medium displays a particle which is moved by the coming ice front for ~313 µm. Frame i is an overlay of g and h where you
can see how the border is minimally changed (in a wave manner). The up move of the grey line compared to the white line
is at the point of one asterisk ~16µm and at the two ~21µm. j–l: islets of Langerhans encapsulated in alginate; cryopreservation
solution: culture medium + 7% Me2SO. Crystallisation starts in the extracellular medium and is retarded by the alginate
bead. Scale bars a–f and j–l: 200 µm. Scale bars g–i: 100 µm
Moreover, Fig. 3(g–i) shows the impact of the ice front
hitting the cell colony. Before this strike, the colony is
moved in a wave like manner. In these pictures only
very small changes are visible due to the way of
presentation. So, there seems to be a mechanical stress
placed on the cells.
By encapsulation in an alginate matrix, the cells
(pancreatic islets) are more protected against the ice
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containing isoosmolar trehalose, the colony seems to
be vitrified. Vitrification is a very successful tool for
cryopreservation of human embryonic stem cells [32,
39]. But vitrification cannot really be proven by mic-
roscopy.
Not only the ice structure is affected by the colony,
but also the colony seems to be mechanically pushed
by the extracellular ice formation (Fig. 3(g–i)). This
stress might be a main reason for poor cryopreservation
results with cells frozen adherent to a substrate. The
ice front might push the cells and possibly disrupt the
monolayer. For cell aggregates in suspension the ice
front might be detrimental in another way, it possibly
causes injuries. An alginate bead as a first surface for
the ice crystals to arrive might be a solution (Fig. 3(j–
k). With cryomicroscopy we cannot see how ice crys-
tals are located inside the alginate beads and inside
the colonies. A high resolution method such as freeze-
substitution electron microscopy must be used applied.
Long-term stability of stored cells
Modern cryobanks store large numbers of objects
long-term in or over liquid nitrogen and there are
situations in which the temperature rises above
–130°C, the glass transition temperature of water.
Vysekantsev et al. [35] demonstrated for three cell
lines and for yeast and bacteria that a cyclic tempe-
rature change up to 100°C for mammalian cells leads
to a significant loss of post-thaw viability. These
experiments show clearly that those influences have
to be investigated for different cell lines and types.
Therefore, we have built up a system in which those
effects can be studied without any side effects like
transportation. The self-made cycling device (Fig. 4)
consists of a sample chamber within an elevator system
in a vacuum isolated liquid nitrogen storage vessel.
The level of liquid nitrogen is automatically maintained
through connection to a liquid nitrogen storage tank. A
supplemented with 10% FBS and 0.1 mg/ml genta-
mycin (all PAN, Aidenbach, Germany). After incuba-
tion for 30min at 4°C in cryomedium (culture medium
containing 5% Me2SO) cells were frozen in IBMT
miniaturised cryosubstrates in a self-made freezing
device at 1°C/min from 4°C to –80°C. After freezing,
samples were stored overnight in liquid nitrogen before
cycling. Cell samples were inserted into the cycling
device. One control group remained in liquid nitrogen;
another was left at –80°C. After cycling, samples were
stored for a minimum of one hour at –196°C before
thawing and vitality testing.
Our study of the warming speeds at different places
in a cryorack showed clearly the need of investigation
of repeated warming effects on deep frozen cells. On
pulling out a cryorack from the tank, warming up to
–80°C occurs within 3 min and after approximately
12 min a temperature of –20°C was reached (data not
shown). After cycling the cell samples 12 times from
liquid nitrogen to about –80°C with holding at each
temperature for twelve hours (Fig. 5a), we could not
find a loss in post-thaw vitalities for different mamma-
lian cell lines compared to the control stored at –196°C
over the whole period (Fig. 5b). Fig. 5b shows post
thaw vitalities with standard deviation. Experiments
were repeated for four times. Using this system we
did not decrease cell viability by 12 temperature cycles
to –90°C. This contrasts with the findings of Vyse-
kantsev et al. [35]. Additionally, Galmes et al. [6]
showed that storage at a constant –80°C for up to 10
years did not influence haematopoietic cell viability.
Improvement of cryopreservation of adherent
stem cells using gel-like matrix
Cryopreservation of hESCs is a field of great
interest despite many difficulties and unsolved prob-
lems. It is known that these cells do not survive well
the freeze/thaw cycle if dispersed to single cell level
Fig. 4. Schematic of the cycling system. A copper cylinder (5) with a
heater (3) at the top is placed into a storage tank (7); with a drive (2) and
an elevator system the sample chamber containing two temperature
sensors (4) can be moved to a height giving the desired temperature;
the liquid nitrogen (6) level is automatically maintained (1) throughout
experiments.
vertical temperature gradient is generated
between liquid nitrogen at the bottom and
an electrical heat source at the top of a clo-
sed copper cylinder. A controlled elevator
system adjusts the height of the cell sample
to achieve the desired temperature. The
sample temperature is controlled through
two sensors one at the top of the sample
chamber and one directly on top of the
sample. Temperature data were logged in
a computer file. For long-term stability
evaluation L929 mouse fibroblasts and the
human cancer cell line PC3 (both DSMZ,
Braunschweig, Germany) were cultured
and harvested under standard conditions.
L929 cells were cultured in DMEM supple-
mented with 10% FBS and 0.1 mg/ml
gentamycin. PC3 cells were cultivated in a
1:1 mixture of RPMI 1640 and Ham’s F12,
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[8]. Slow freezing protocols, usually with relatively high
amounts of Me2SO (in the range of 10%) showed only
poor survival and functionality rates of 10–36% [7, 15,
19]. An improvement has been reported by addition of
the extracellular matrix protein type IV collagen [19]
or through addition of trehalose to freezing and thawing
medium [37], so that 48% recovery of undifferentiated
cells could be achieved. Also some promising results
have been reported from Ware et al. with rates in the
range of 80% [36] if cells were frozen with slow rates
in small volumes of 250 µl. These high levels of post-
thaw viability and functionality are usually only reached
if vitrification is used [31, 32, 39]. Unfortunately, this
method is very time and labour intensive and cannot
be automated, sterile cryostored over liquid nitrogen
and is therefore not suitable for bulk cryopreservation.
Another promising approach is to freeze cells in
their native state that means adherent to their culture
surface with or without feeder cells [9–11, 14]. Ji et al.
[14] reported good results if a gel layer was used. They
showed a recovery of up to 82%. Heng et al. demon-
strated that despite good vitalities directly after thaw-
ing, human embryonic stem cells died within hours due
to apoptosis [9–11]. Addition of apoptosis inhibitor to
the freeze and thaw medium can improve cryopreser-
vation [11]. A solution to these problems would be
important in cell replacement therapy. In this field very
promising studies have been reported [28, 30].
In this paper we report a successful cryopreser-
vation of adherent human embryonic stem cells using
a gel-like matrix. H1 embryonic stem cells were
cultured as described above. ECM gel (Sigma-Aldrich
Chemie GmbH, Schnelldorf, Germany) was diluted in
Dulbecco‘s modified Eagle‘s medium (Invitrogen,
Paisley, UK) to a final concentration of approximately
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Fig. 5. Graph a displays the temperature profile measured during one trial of sample cycling, temperature measured at the
top of the sample chamber (light grey line) and directly on the samples (dark grey line).
In b the white bars show the post-thaw vitalities after twelve cycles from –196 to –80°C. The black bars are the controls
constantly held at –80°C. The grey bars are the controls stored at –196°C. Experiments were repeated four times. Error bars
are standard deviation.
0.5 mg/ml. Non-adhesive Petri dishes were covered
with ECM gel and dried 30 minutes. Feeder cell
suspension was added in a density 1×105 cells/ml onto
ECM covered dishes. Inactivated feeder cells were
cultured for 1–3 days on gel before adding H1 cells.
H1 were harvested by collagenase type IV treatment
and cultured for 2–3 days on ECM + feeder cells.
Before cryopreservation a second gel layer (diluted
1:10) was drawn on the samples. ECM was added for
30 min at room temperature above the cells. Remaining
liquid was discarded and cryopreservation solution
(culture medium + 15% heat inactivated FBS, contain-
ing 10% ME2SO) was added drop by drop to the cells
in a total volume of 0.6 ml per Petri dish (diameter
3.5 cm). After incubation for 30 min at 4°C, samples
were frozen to –80°C at 1°C/min in a computer
controlled freezing device (SYLAB, Neupurkersdorf,
Austria). Cells were stored until thawing in –80°C
freezer. A control (non-frozen) sample was stained
with FDA/EB and pictures were taken for an imaging
based vitality evaluation method. Samples were thawed
in a 37°C water bath, special care was taken that no
water came inside the cell samples. The samples were
stained directly, 24 h and 48 h after thawing. After
that the same samples were prepared for scan-ning
electron microscopy (SEM). Petri dishes with cells
were wshed with 0.25M Hepes (PAN, Aidenbach,
Germany) buffer solution, fixed overnight at 4°C with
2% glutaraldehyde (Agar Scientific, Essex, UK) in
sodium cacodylate buffer (Agar Scientific, Essex, UK)
and treated with 2% osmium tetroxide (Roth, Karlsruhe,
Germany), 1% tannic acid (Sigma-Aldrich Chemie
GmbH, Schnelldorf, Germany) and 1% uranyl acetate
(TED PELLA INC, Redding, CA) in water (PAN,
Aidenbach, Germany) as previously described [16] and
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modified [17]. Then the cells were dehydrated in
increasing series of ethnol, dried in automated Polaron
Range critical point dryer CPD-7501 (Quorum Techno-
logies Ltd.) and prepared for SEM. Samples were
examined in a field emission scanning electron micro-
scope FESEM XL30 (Phillips, USA) using secondary
electron (SE) modes with 10 kV accelerating voltage
and 10 mm working distance.
Before freezing most of the cell colonies of different
sizes were vital and attached to the substrate (Fig.
6a). After thawing approximately 30% hESCs colonies
were detached from the substrate, but more than 85%
of the remaining H1 embryonic stem cells were vital
even 24 and about 95% of cells 48 h later (Fig. 6b, c,
d; Fig. 7). 3 days after thawing the H1 colonies were
harvested by collagenase (see above) and successful
re-cultivated (Fig. 6e, f).
SEM of the same objects has shown that H1 cell
colonies were attached directly to ECM gel before
(Fig. 8a, b, c) and after (Fig. 8, d–l) cryopreservation.
The colonies in the non-frozen control showed close
cell-cell contacts and their surfaces were covered with
microvilli (Fig. 8b, c). Sometimes the colonies in control
were partly detached from the substrate (perhaps,
during SEM preparation) and numerous filaments and
blebs were visible on the reverse side (Fig. 8a, insert).
Most of the stem cells had immediately (Fig. 8(d–f)),
24 h (Fig. 8(g–i)) and 48 h (Fig. 8(j–l)) after
cryostorage a surface relief comparable with the non-
frozen control (Fig. 8b, c). However, some cells were
detached immediately after thawing (Fig. 8e, arrows).
In several colonies we saw a smoothing of cell surface,
a sign of low temperature stress reaction (Fig. 8f,
Fig. 6. Representative images of vitality testing of H1 stem cell colonies with feeder cells frozen with ECM gel before (a),
immediately (b), 24h (c), 48h (d) after cryopreservation. and 3 days after post thawing cultivation (e, f). Scale bars are
100 µm, exept in in e, which is 500 µm.
Post-thaw time, h
Fig. 7. Vitality testing for H1 stem cell colonies after
cryopreservation using ECM gel and serum-contained me-
dium with 10% Me2SO.
double arrow). 24 h after thawing we have observed
also the development of cell damages, (Fig.8, h,
asterisks) as well as absolutely smooth damaged cells
with maceration and holes on the surfaces (Fig. 8h,
double asterisks). The whole recovery of cell surface
relief can be observed 48 hours after thawing (Fig. 8j,
k, l).
It is known that hESCs can be grown in culture as
colonies on feeder cells and can remain non-differen-
tiated or be differentiated in a desired way, e.g. cardiac
differentiation [28, 30]. There are three ways to cryo-
preserve hESCs. Slow freezing of dispersed colonies
is usually not successful and needs high levels of cryo-
protectant [14, 15, 19]. Vitrification is a powerful tool
but because of the already mentioned limitations not
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suitable. Cryopreservation of adherent hESCs with or
without feeder cells can be an alternative for stem cell
storage, especially, due to the reduction of differentia-
tion after thawing [14]. Our design with ECM-coating
of plastic surfaces is comparable with Matrigel™[14].
In contrast to the results of Heng et al. [9] the first
cryopreservation of H1 embryonic stem cells on the
ECM gel (Fig. 6(d–f)) was successful. Combined fluo-
rescent and SEM of the same colonies in our study
have shown that, immediately after thawing, there is a
Fig. 8. H1 embryonic stem cells cultured and cryopreserved with serum-containing medium and 10% Me2SO using ECM
gel (a, b, c – control; d, e and f – cells immediately after thawing; g, h and i – 24 h later; j, k and l – 48 h later): a – overview
of cell colonies; insert – outside of colony; note of structure similar to the extracellular matrix; b, c – cell surface of
control; the embryonic stem cells are covered with microvilli; d, e, f – structure of stem cell colony immediately after
thawing: note detachment (e, arrows) and smoothing (f, double arrows) of some cells; g, h, i – blebs on the surface of some
cells (asterisks) and appearance of the smooth cells with damaged surfaces (double asterisks) 24h after thawing; j, k, l –
whole recovery of microvillous relief of stem cell colony 48 h after thawing. Scale bars are presented in the pictures.
stress reaction (smoothing of cell surface), but only a
little permanent damage. 24 hours after thawing hESCs
colonies some damages as well as apoptosis (blebs,
Fig. 8h) were developed.
Perhaps, good preservation with ECM-gel is achie-
ved by the following reasons. Firstly, the cells may
contract with the ECM and therefore not detach from
the substrate. Secondly, filaments of ECM (as in
Fig. 8a, insert) may absorb water, thereby avoiding
harmful ice crystallisation. This opens up new pers-
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pectives for creating novel MST cryosubstrates with
different ECM proteins for screening and cryopreser-
vation of embryonic stem cells with optional differen-
tiation after thawing.
Summary and outlook
1. We have presented novel microsystem-based
tools and devices for cryopreservation. Comparison
with standard cryovials has shown that the reduction
of concentration of toxic CPA‘s is possible and can
yield a high viability for adult stem cells.
2. Using new cryoequipment for the study of stabi-
lity in long-term storage of cells, we have shown a
constant viability of cancer cells throughout repeated
freezing cycles.
3. We have demonstrated a possibility of precise
imaging of freezing processes of multicellular systems
by means of high-speed video cryomicroscopy. This
method allows new insights in the phase transition
mechanisms by freezing of embryonic stem cell
colonies. Fluidic simulation and modelling will allow
a cell specific freezing procedure design.
4. More than 85% of the adherent H1 hESCs
remain vital up to 48 hours after cryopreservation and
following re-cultivation using gel-like matrices. This
opens new avenues for stem cell cryopreservation.
The new devices and methods will lead to new bio-
banking procedures and standards [42]. However, the
methods for investigation of hESCs recovery after
cryopreservation are still missing. In this case techno-
logy for parallel long-term video microscopy with high
numbers of cells for analysis of cryoinduced hESCs
differentiation is needed.
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